Mink Therapeutics (NasdaqCM:INKT) Q3 2025 Earnings Call November 14, 2025 08:30 AM ET Company ParticipantsJennifer Buell - President and CEOStefanie Perna-Nacar - Chief Communications and Government Relations OfficerChristine Klaskin - VP and Finance, Principal Financial and Accounting OfficerConference Call ParticipantsMayank Mamtani - AnalystNone - AnalystEmily Bodnar - Research AnalystOperatorGood morning and welcome to MiNK Therapeutics' Third Quarter 2025 Conference Call and Webcast. All participants w ...